IMCD Appoints Two New Executive Committee Members
IMCD has appointed Fenna van Zanten, IMCD Group Director, Mergers & Acquisitions (M&A), and Andreas Igerl, President, IMCD APAC, as new members to its executive committee, effective Jan. 1, 2024.
Van Zanten, a Dutch national, holds a master’s degree in law from Erasmus University in Rotterdam, the Netherlands. After a career in law, she joined IMCD in 2020 as a legal counsel, focusing on M&A. She was appointed Director of M&A in 2022, a role in which, she has further strengthened and standardized the company’s M&A process and oversees all acquisitions globally.
Igerl is German and holds a master’s degree in business administration from the University of Applied Science for Economy and Management in Munich, Germany. He has been with IMCD since 2019, first as Business Unit Manager of Advanced Materials in Germany, and then as the Managing Director of IMCD China. In 2022, he relocated to Singapore to lead the IMCD APAC region as President.
most read
CHEManager International Media Kit 2026
Compelling solutions through strategic partnerships
Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Merck Acquires Chromatography Business from JSR Life Sciences
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.